Andrew McElligott

“A good litigator prepares and knows the advantages of being able to make a better argument for the other side than they can make for themselves.” 

Drew McElligott focuses his practice on patent and trademark litigation. He represents leading companies in the pharmaceutical and medical device sectors, as well as consumer products manufacturers.

Prior to law school, Drew spent four years conducting scientific research at the Loyola University Cardiovascular Institute, where he gained invaluable experience in a variety of surgical and diagnostic procedures as well as viral and histological techniques.  This strong technical background informs every aspect of Drew’s litigation practice, from understanding the core technologies of his clients’ products to crafting creative legal strategies that protect and defend their innovations.

Drew works to achieve his clients’ legal and business goals in the short term while also thinking forward to protect their long-term interests.  Maintaining that perspective is part of his commitment to providing comprehensive and efficient legal service.

  • J.D.
    The John Marshall Law School, 2014
  • B.S., Science Pre-Professional
    University of Notre Dame, 2007
Bar Admissions
  • Illinois
Experience | Overview
  • Co-authored multiple scientific articles in medical and cardiology publications, and published article on licensing-related issues for the International Trade Commission Trial Lawyers’ Association.
  • Performed extensive legal research as a professor’s assistant at The John Marshall Law School.
  • Served as Lead Articles Editor of The John Marshall Review of Intellectual Property Law.
Experience | Legal
Brinks Gilson & Lione, Chicago, IL
Associate, September 2014-Present
Summer Associate, May 2013-August 2013
Experience | Non-Legal
Loyola University Cardiovascular Institute, Maywood, IL
Research Assistant I and Lead Technician, February 2008-August 2011
  • "2017 Litigation Update," Brinks Webinar, June 14, 2017
Press Releases & Events
November 09, 2017

On Thursday, November 9, 2017, at 12:00pm CT, David Bernard, Joshua James, and Andrew McElligott, attorneys with Brinks' Post-Grant Patent and Medical Device practice groups, will present the webinar, "Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings." Jason Schigelone...

November 01, 2017

CHICAGO—Brinks Gilson & Lione intellectual property lawyers David Bernard, Joshua James, and Andrew McElligott will present "Selected Issues Impacting Biopharma and Medical Device Patent Post-Grant Review Proceedings,” in a webinar at noon CST on Thursday, November 9, 2017...

June 14, 2017

On Wednesday, June 14, 2017, at 12:00pm CT, the Litigation practice group will present the webinar, "2017 Litigation Update." Attorneys David P. Lindner, James K. Cleland, Alex J. Fernandez, and Andrew McElligott...

September 15, 2014
CHICAGO—In response to rising demand for its core intellectual property legal services, Brinks Gilson & Lione recently announced the hiring of nine new associates. Brinks' incoming associates have professional and educational ...
  • Hon. Howard T. Markey Distinguished Scholar, 2011-2014
  • Lead Articles Editor, The John Marshall Review of Intellectual Property Law
  • Board Member, Trial Advocacy and Dispute Resolution Honors Council
  • CALI Awards in Torts, Property, and Constitutional Law
  • Phi Alpha Delta Legal Fraternity
  • The Order of John Marshall